drugset / Trial / NCT02095366

Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting

NCT02095366

RandomizedParallel-groupTriple-blindTreatment

Summary

Intranasal (IN) administration of opiates is an appealing non-invasive way of treating acute traumatic pain in prehospital and Emergency departments (ED). The investigators hypothesize that IN administration of Sufentanil is equal as compared with Intra veinous (IV) administration of Morphine wich is widely recommended in ED. The investigators study is a multicentric, comparative, randomized, double-blind, double-placebo study, comparing quality of analgesia in both groups 30 minutes after first administration of opiates. The investigators also asses side effects and patient satisfaction in both groups.

Timeline

Start
2013-08-02
Primary completion
2016-04-10
Completion
2016-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 0.05 mg/kg Intravenous
Comparator Morphine Other / unclassified 0.1 mg/kg Intravenous
Subject Sufentanil Other / unclassified 0.15 ug/kg Intranasal
Subject Sufentanil Other / unclassified 0.3 ug/kg Intranasal

Indications

No indication recorded.